Diagnostic Center | September 28, 2022
South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
There is also a growing interest in whole generation sequencing (WGS)
There is also a growing interest in whole generation sequencing (WGS)
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
Launching in 2022, its availability will be expanded to the global market
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
Subscribe To Our Newsletter & Stay Updated
